Institut Curie — Paris

Public research footprint of Institut Curie, compiled from the ClinicalTrials.gov public registry.

800

Registered studies

312

Active

176

Recruiting now

362

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Breast Neoplasms · Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT06772623 — Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… (Recruiting)
NCT04892173 — JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut Curie?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.